Women undergoing surgery who are treated with unfractionated heparin have a high incidence of heparin-induced thrombocytopenia (HIT), according to a report in the Nov. 1 issue of Blood.
Women undergoing surgery who are treated with unfractionated heparin have a high incidence of heparin-induced thrombocytopenia (HIT), according to a report in the Nov. 1 issue of Blood. The risk from low-molecular-weight heparin is minimal, regardless of treatment setting.
Theodore E. Warkentin, MD, of McMaster University in Hamilton, Ontario, Canada, and colleagues noticed a high incidence of HIT in women after cardiac or orthopedic surgery, according to national databases. In this study, they set out to examine the link more closely using prospective studies comparing unfractionated heparin with low-molecular-weight heparin (LMWH).
Three separate studies showed overrepresentation of women with HIT. Analysis of the data showed that HIT was more likely to occur in women than men (common OR, 2.37) and in surgical versus medical patients (common OR, 3.25). Unfractionated heparin was also much more likely to cause HIT than LMWH in women versus men (common OR, 9.22 vs. 1.83) and in surgical versus medical patients (common OR, 13.93 vs. 1.75).
Warkentin TE, Sheppard JI, Sigouin CS, et al. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood. 2006;108:2937-2941.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More